Archean Chemical Industries (ACI) Q1 26/27 earnings summary

Executive summary

• Q1 FY27 saw consolidated revenue rise to ₹3,328 million, up 11% year-over-year, driven by record bromine volumes and improved derivatives performance, despite logistics and cost headwinds.

• Profit after tax for Q1 FY27 was ₹3,035.44 lakhs, down from ₹4,014.30 lakhs in Q1 FY26 but up from ₹1,222.80 lakhs in Q4 FY26.

• Strategic focus remains on consolidating core businesses, scaling derivatives, and investing in advanced materials, semiconductor, and energy storage projects.

• Exports accounted for nearly two-thirds of revenue but faced headwinds from West Asia conflict, leading to higher transit times and freight costs.

• Management remains confident about the renewal of the land lease for the Gujarat production facility, which is critical for ongoing operations.

Financial highlights

• Consolidated total income for Q1 FY27 was ₹33,280.52 lakhs, up 14% year-over-year and 9% sequentially.

• Standalone EBITDA reached ₹888.7 million, up 26.3% sequentially, with margins expanding to 25.3%.

• Consolidated PAT was ₹3,035.44 lakhs, more than double the prior quarter.

• Consolidated EPS for Q1 FY27 was ₹2.48, compared to ₹3.25 in Q1 FY26 and ₹1.13 in Q4 FY26.

• Standalone reserves (excluding revaluation) stood at ₹1,97,334.08 lakhs as of June 30, 2026.

Outlook and guidance

• Salt volumes expected to normalize from Q3 as highway construction completes and logistics improve.

• Bromine volumes guidance of 20,000–25,000 tons for FY27 reaffirmed, with pricing expected to remain firm barring spot market volatility.

• SOP revenue is expected to maintain momentum, with meaningful contribution anticipated in H2 FY27.

• Flame retardant bromine project is expected to come online in the next 12–18 months.

• Expansion in energy storage and semiconductor sectors positions the company for long-term growth.